发明名称 Substituted quinolines for the treatment of cancer
摘要 Compounds of formula G1-L-G2, where -G1 is a radical structurally close to cryptolepine, -L- is a single covalent bond or a covalent linking biradical selected from (CH2)rNR′″(CH2)s and —(CH2)rNR′″(CH2)sNR″″(CH2)t—, —R′″ and —R″″ are radicals, same or different, selected from the group consisting of H and (C1-C3)-alkyl; r, s and t are an integer from 1 to 3 and, -G2 is H or a radical structurally close to -G1, are intercalators. They are compounds which intercalate between DNA base pairs, and are useful as therapeutic agents against cancer, as assess by an in vitro test of cytotoxicity with human leukemia cells Jurkat E6-1 and human carcinoma cells GLC-4. Preferred compounds are those where -G1 is bonded to -L- through a carbonyl amino and -L- is —(CH2)3NCH3(CH2)3 or —(CH2)2NCH3(CH2)sNCH3(CH2)2— where s =2 or 3. -G1 is a radical selected from (IIa) y (IIb); -G2 is a radical selected from H, a radical of formula (IIa), a radical of formula (IIb), the N-radical of 1,8-naphthalimide, the C4-radical of 2-phenylquinoline, and the C9-radical of acridine.
申请公布号 US7728000(B2) 申请公布日期 2010.06.01
申请号 US20040580140 申请日期 2004.11.18
申请人 CRYSTAX PHARMACEUTICALS;UNIVERSITAT POLITECNICA DE CATALUNYA;CONSEJO SUPERIOR DE INVESTIGACTIONES CIENTIFICAS 发明人 BOFARULL JUAN AYMAMI;CAPELLA MIQUEL COLL;SOLDEVILA AMADEO LLEBARIA;MUNOZ ISABEL NAVARRO
分类号 A61K31/4745;A61K38/00;C07D471/04;C07D519/00;C07H21/00;C07K5/00;C07K5/06 主分类号 A61K31/4745
代理机构 代理人
主权项
地址